Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene

Gene

Volumn 214, Issue 1-2, 1998, Pages 35-44

  Huber, R ^a   Schlessinger, D ^a   Pilia, G ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Talassemie e Anemie Mediterranee   (Italy)

Author keywords

DNA sequence; Proteoglycan; Transcription factor; Transcriptional regulation

Indexed keywords

COMPLEMENTARY DNA; DEOXYRIBONUCLEASE I; DNA; GLYPICAN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA FOOTPRINTING; GENE ACTIVATION; GENE DELETION; GENE FUSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CACO-2 CELLS; CELL LINE; DNA; DROSOPHILA; GENE EXPRESSION REGULATION; GLYPICANS; GROWTH DISORDERS; HELA CELLS; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE PROBES; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; SP1 TRANSCRIPTION FACTOR; SYNDROME;

EID: 0032479501     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00233-9     Document Type: Article

References (30)

1. Baker D.L., Dave V., Reed T., Periasamy M.J. Multiple Sp1 binding sites in the cardiac/slow twitch muscle sarcoplasmic reticulum Ca2+-ATPase gene promoter are required for expression in Sol8. J. Biol. Chem. 271:1996;5921-5928.
2. Behmel A., Plochl E., Rosenkranz W. A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome. Hum. Genet. 67:1984;409-413.
3. Blake M.C., Jambou R.C., Swick A.G., Kahn J.W., Azizkhan J.C. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol. 10:1990;6632-6641.
4. Boisclair Y.R., Brown A.L., Casola S., Rechler M.M. Three clustered Sp1 sites are required for efficient trnscription of TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J. Biol. Chem. 268:1993;24892-24901.
5. Briggs M.R., Kadonaga J.T., Bell S.P., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science. 234:1986;47-52.
6. Buratowski S. The basics of basal transcription by RNA polymerase II. Cell. 77:1994;1-3.
7. Cohen M.M. Jr. A comprehensive and critical assessment of overgrowth and overgrowth. Adv. Hum. Genet. 18:1989;181-303.
8. Courey A.J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55:1988;887-898.
9. Gill G., Pascal E., Tseng Z.H., Tjian R. A glutamine rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophilia TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA. 91:1994;192-196.
10. Golabi M., Rosen L. A new X-linked mental retardation-overgrowth syndrome. Am. J. Med. Genet. 17:1984;345-358.
11. Graves B.J., Johnson P.F., McKnight S.L. Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell. 44:1986;565-576.
12. Huber R., Crisponi L., Mazzarella R., Chen C.N., Su Y., Shizuya H., Chen E.Y., Cao A., Pilia G. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5′-promoter and the 3′-terminal ends of the human glypican 3 (GPC3) gene. Genomics. 45:1997;48-58.
13. Hughes-Benzie R.M., Allanson J., Hunter A., Cole T. The importance of differentiating Simpson-Golabi-Behmel and Beckwith-Wiedemann syndromes. J. Med. Genet. 29:1992;928.
14. Jones K.A., Kadonaga J.T., Luciw P.A., Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science. 232:1986;755-759.
15. Kadonaga J.T., Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc. Natl. Acad. Sci. USA. 83:1986;5889-5893.
16. Kaufmann J., Verrijzer C.P., Shao J., Smale S.T. CIF, an essentail cofactor for TFIID-dependent initiator function. Genes Dev. 10:1996;873-886.
17. Lee J.-K., Tam J.W.O., Tsai M.-J., Tsai S.Y. Identification of cis- and trans-acting factors regulating the expression of the human insulin receptor gene. J. Biol. Chem. 267:1992;4638-4645.
18. Lu J., Lee W., Jiang C., Keller E.B. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J. Biol. Chem. 269:1994;5391-5402.
19. McEwen D.G., Ornitz D.M. Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors. J. Biol. Chem. 273:1998;5349-5357.
20. Majello B., Arcone R., Toniatti C., Ciliberto G. Constitutive and IL-6-induced nuclear factors that interact with human C-reactive protein promoter. EMBO. J. 9:1990;457-465.
21. Neri G., Marini R., Cappa M., Borrelli P., Opitz J.M. Simpson-Golabi-Behemel syndrome: an X-linked encephalo-tropho-schisis. Am. J. Med. Genet. 30:1988;287-299.
22. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:1992;240-247.
23. Pilia G., Hughes-Benzie R.M., MacKenzie A., Baybayan P., Chen E.Y., Huber R., Neri G., Cao A., Forabosco A., Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behemel overgrowth syndrome. Nat. Genet. 12:1996;241-247.
24. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors. 5:1991;3-18.
25. Simpson J.L., Landey S., New M., German J. A previously unrecognized X-linked syndrome of dysmorphia. Birth Defects. 11:1975;18-24.
26. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
27. Verrijzer C.P., Chen J.L., Yokomori K., Tjian R. Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell. 81:1995;1115-1125.
28. Wang Y., Hahn T.M., Tsai S.Y., Woo S.L. Functional characterization of a unique liver gene promoter. J. Biol. Chem. 269:1994;9137-9146.
29. Weksberg R., Shen D.R., Fei Y.L., Song Q.L., Squire J. Disruption of insulin-like growth factor 2 imprintng in Beckwith-Weidemann syndrome. Nature Genet. 5:1994;143-150.
30. Yayon A., Klagsbrun M., Esko J.D., Leder P., Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.